NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Freeline Therapeutics Holdings plc (NASDAQ: FRLN)

 
FRLN Technical Analysis
5
As on 16th Feb 2024 FRLN STOCK Price closed @ 6.48 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.23 & Strong Buy for SHORT-TERM with Stoploss of 0.75 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

FRLNSTOCK Price

Open 6.49 Change Price %
High 6.49 1 Day 0.00 0.00
Low 6.48 1 Week 0.08 1.25
Close 6.48 1 Month 0.15 2.37
Volume N/A 1 Year 5.65 680.72
52 Week High 6.75 | 52 Week Low 0.24
 
NASDAQ USA Most Active Stocks
GNLN 0.01 0.00%
HCTI 0.03 50.00%
AMRS 0.14 100.00%
NVDA 144.69 1.92%
NCNA 0.13 18.18%
LCID 2.15 2.38%
LMDX 0.02 0.00%
SONM 1.68 80.65%
AKTS 0.04 0.00%
AMD 126.39 8.81%
 
NASDAQ USA Top Gainers Stocks
ZWZZT 26.52 3688.57%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
ZJZZT 22.50 150.84%
ZVZZT 36.25 139.43%
GLSPT 33.43 138.62%
 
NASDAQ USA Top Losers Stocks
LGHLW 0.00 -100.00%
OTIC 0.01 -91.67%
RGC 60.00 -89.92%
PTRAW 0.23 -89.59%
NBSTU 2.00 -82.44%
TBIO 0.05 -80.00%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
OMQS 0.06 -66.67%
 
 
FRLN
Daily Charts
FRLN
Intraday Charts
Whats New @
Bazaartrend
FRLN
Free Analysis
 
FRLN Important Levels Intraday
RESISTANCE6.50
RESISTANCE6.49
RESISTANCE6.49
RESISTANCE6.49
SUPPORT6.47
SUPPORT6.47
SUPPORT6.47
SUPPORT6.46
 
FRLN Forecast June 2025
4th UP Forecast6.9
3rd UP Forecast6.77
2nd UP Forecast6.68
1st UP Forecast6.6
1st DOWN Forecast6.36
2nd DOWN Forecast6.28
3rd DOWN Forecast6.19
4th DOWN Forecast6.06
 
FRLN Weekly Forecast
4th UP Forecast6.71
3rd UP Forecast6.64
2nd UP Forecast6.59
1st UP Forecast6.55
1st DOWN Forecast6.41
2nd DOWN Forecast6.37
3rd DOWN Forecast6.32
4th DOWN Forecast6.25
 
FRLN Forecast2025
4th UP Forecast22.8
3rd UP Forecast17.57
2nd UP Forecast14.33
1st UP Forecast11.1
1st DOWN Forecast1.86
2nd DOWN Forecast-1.37
3rd DOWN Forecast-4.61
4th DOWN Forecast-9.84
 
 
FRLN Other Details
Segment EQ
Market Capital 107766424.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
FRLN Address
FRLN
 
FRLN Latest News
 
Your Comments and Response on Freeline Therapeutics Holdings plc
 
FRLN Business Profile
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is FLT180a, a gene therapy product candidate that is in Phase 1/2 dose-finding clinical trials in adult males for the treatment of hemophilia B. The company's products also include FLT190, which is in dose-escalating Phase 1/2 clinical trials for the treatment of Fabry disease; FLT201, a liver-directed gene therapy product candidate to treat type 1 Gaucher disease; and FLT210, a liver-directed gene therapy product candidate for the treatment of hemophilia A. In addition, it has research programs in various indications for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom. Address: Stevenage Bioscience Catalyst, Stevenage, United Kingdom, SG1 2FX
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service